Expanding $1 Billion Brand Club Fits In J&J Consumer Big Picture
This article was originally published in The Tan Sheet & The Rose Sheet
J&J consumer sector Chairman Jorge Mesquita says the Tylenol analgesic and cough/cold line is an OTC brand the firm expects to join its $1bn club, which already includes the Neutrogena skin care, Listerine oral care and Johnson's Baby lines.
You may also be interested in...
In online video ads for Tylenol, the firm says “for everything we do, we know you do so much more.” CFO Dominic Caruso says the ad campaign will reconnect the brand with consumers.
Substantially more consumers in 2022 report sleep issues, allergies and skin problems than in 2018 while using quit smoking aids has dropped, according to CHPA’s latest “Value of OTC Medicines” survey. Average annual household spending on OTCs is $645.
FDA “understands that manufacturers expect availability to continue to increase in the near future.” CHPA is working with members “focused on safeguarding the US supply by maximizing capacity to produce and direct product to where it is needed most.”